(FXO) First Trust Financials - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US33734X1357

FXO: Financial, Services, Sector, Exposure, Companies

The First Trust Financials AlphaDEX Fund (FXO) is an actively managed exchange-traded fund that focuses on the financial services sector. By employing the AlphaDEX selection methodology, the fund aims to outperform traditional passive indices by identifying stocks with high potential for generating positive alpha.

The funds investment strategy involves allocating at least 90% of its net assets to securities that comprise the underlying index, which is a modified equal-dollar weighted index derived from the Russell 1000 Index. This approach enables the fund to maintain a diversified portfolio while emphasizing stocks that are likely to drive returns in the financial services sector.

From a technical analysis perspective, the funds price action indicates a bullish trend, with the short-term Simple Moving Average (SMA20) at $54.01 and the long-term SMA200 at $53.16. The Average True Range (ATR) of 0.73, equivalent to 1.35%, suggests moderate volatility. Given the current price of $54.16, we can expect the fund to continue its upward momentum, potentially targeting the 52-week high of $58.36.

Fundamentally, the funds Assets Under Management (AUM) stand at $2.069 billion, indicating a sizable presence in the market. As the financial services sector continues to evolve, the funds AlphaDEX selection methodology is well-positioned to capitalize on emerging trends and opportunities. With its robust investment strategy and diversified portfolio, we forecast that FXO will maintain its competitive edge, potentially outperforming traditional passive indices in the financial sector.

Combining technical and fundamental insights, our forecast suggests that FXO may experience a moderate increase in value, driven by its strong investment strategy and favorable market conditions. As the fund continues to adapt to changing market dynamics, we expect it to remain a viable option for investors seeking exposure to the financial services sector.

Additional Sources for FXO ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

FXO ETF Overview

Market Cap in USD 2,069m
Category Financial
TER 0.62%
IPO / Inception 2007-05-08

FXO ETF Ratings

Growth Rating 72.7
Fundamental -
Dividend Rating 51.8
Rel. Strength -3.02
Analysts -
Fair Price Momentum 54.61 USD
Fair Price DCF -

FXO Dividends

Dividend Yield 12m 2.18%
Yield on Cost 5y 5.02%
Annual Growth 5y 3.66%
Payout Consistency 93.2%
Payout Ratio %

FXO Growth Ratios

Growth Correlation 3m 52.3%
Growth Correlation 12m 51.1%
Growth Correlation 5y 71.4%
CAGR 5y 18.44%
CAGR/Max DD 5y 0.64
Sharpe Ratio 12m 1.08
Alpha 9.83
Beta 0.972
Volatility 20.98%
Current Volume 63.7k
Average Volume 20d 55.3k
What is the price of FXO shares?
As of June 20, 2025, the stock is trading at USD 53.83 with a total of 63,700 shares traded.
Over the past week, the price has changed by -0.61%, over one month by -1.88%, over three months by +1.34% and over the past year by +19.21%.
Is First Trust Financials a good stock to buy?
Yes. Based on ValueRay´s Analyses, First Trust Financials (NYSE ARCA:FXO) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 72.70 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FXO is around 54.61 USD . This means that FXO is currently overvalued and has a potential downside of 1.45%.
Is FXO a buy, sell or hold?
First Trust Financials has no consensus analysts rating.
What are the forecasts for FXO share price target?
According to our own proprietary Forecast Model, FXO First Trust Financials will be worth about 61.7 in June 2026. The stock is currently trading at 53.83. This means that the stock has a potential upside of +14.69%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 61.7 14.7%